The potential rescheduling of cannabinoids, particularly at the federal level, is generating considerable buzz within the market. A shift away from Schedule I status, often regarded as outdated and hindering progress, https://geilebookmarks.com/story20634064/cannabinoid-rescheduling-a-development-catalyst